Elite 50% OFF Act now – get top investing tools

00

Days

00

Hours

00

Mins

00

Sec

Register Now!

5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment

By Ekta Bagri | July 02, 2025, 9:28 AM

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Exelixis, Inc. (EXEL): Free Stock Analysis Report

Alkermes plc (ALKS): Free Stock Analysis Report

Verona Pharma PLC American Depositary Share (VRNA): Free Stock Analysis Report

Kiniksa Pharmaceuticals International, plc (KNSA): Free Stock Analysis Report

Immunocore Holdings PLC Sponsored ADR (IMCR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Latest News

21 min	2 Under-the-Radar Stocks to Buy Heading Into 2026 EXEL Motley Fool
Nov-28	Here's Why Exelixis (EXEL) is a Strong Growth Stock EXEL Zacks
Nov-27	Why Is Alkermes (ALKS) Down 5.5% Since Last Earnings Report? ALKS Zacks
Nov-25	Alkermes to Participate in Two Upcoming Investor Conferences ALKS Business Wire
Nov-20	AGIO Stock Hits 52-Week Low on Mixed Sickle Cell Disease Study Results ALKS Zacks
Nov-20	ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal ALKS Zacks
Nov-19	Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck ALKS Investor's Business Daily
Nov-19	Alkermes prevails over Lundbeck in Avadel bidding war ALKS Pharmaceutical Technology
Nov-19	Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri ALKS Zacks
Nov-19	Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks ALKS Zacks
Nov-19	BAYRY Obtains Approval for Hormone Free VMS Treatment Lynkuet in the EU ALKS Zacks
Nov-19	Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc ALKS PR Newswire
Nov-19	Alkermes escalates bidding war; US biotech risks falling behind China ALKS BioPharma Dive
Nov-19	TD Cowen Asserts Buy Rating as Alkermes plc (ALKS) Delivers Topline Results for Narcolepsy Treatment ALKS Insider Monkey
Nov-18	RHHBY Reports Positive Phase III Data on Breast Cancer Drug ALKS Zacks

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.